Hepatitis C (HCV) is a virus that leads to serious liver complications including
cirrhosis and liver cancer. New, widely available treatments can cure over 95% of HCV-infected
people using a well-tolerated eight-to-twelve-week regimen of once-daily medication. However,
equitable access to HCV cure is not available to many Albertans, as current specialist
referral-based HCV care in Alberta disproportionately fails priority populations, including those
experiencing homelessness, people who inject drugs, incarcerated or previously incarcerated
individuals, or those living in rural areas.
With an expanded scope of practice and the potential to act as the most
accessible health care professional, Alberta pharmacists are well positioned to provide
comprehensive HCV care to patients with chronic uncomplicated HCV infection. While novel,
pharmacist-led HCV care has successfully reduced HCV burden in other jurisdictions, community-based
HCV outreach by pharmacists is a new and largely untapped practice in Alberta. Learn more about this
here!
1 in 100 Albertans have been infected with the Hepatitis C virus! | |
You can have Hepatitis C and not know it! | |
Hepatitis C can cause severe liver disease! | |
Treatments are available that cure Hepatitis C! |
Learn more about Hepatitis C through our video and patient testimonial; additional resources can be found here!
The World Health Organization set an ambitious goal for HCV elimination as a public
health threat by 2030 with a target 80% reduction in the incidence of chronic infections and a 65%
reduction in HCV-related-mortality.
One in 100 Albertans are infected with HCV.
Current specialist referral-based HCV care in Alberta disproportionately fails
priority populations including those experiencing homelessness, people who inject drugs, incarcerated or
previously incarcerated, Indigenous, or those living in rural areas.
LiveRx is an Alberta Innovates Partnership for Research and Innovation in the Health System (PRIHS) program. It is a collaboration between the University of Calgary, the University of Alberta, and Alberta Health Services, with private industry partners.
Pharmacists:
How to participate in the LiveRx study
Hepatitis C Certification Program
Physicians & Other Healthcare Professionals:
Testimonial from a participating community-based organization:
"Over the past few months, the nursing staff of Northreach and I have built such a strong
relationship with the London Drugs pharmacy in Grande Prairie due to the LiveRX project! We have
done HCV testing/treatment events in partnership with the pharmacy. Aside from this we have managed
to collaborate and maintain clients on OAT with little to no resources, access clients'
pharmaceutical forms of birth control and so many other amazing things. Our collaboration on the
premises of the LiveRX project has brought us so much more than we had hoped for and enhanced our
ability to really focus on health promotion and the overall health of our clients."
- Angelina Collins, BNRN, Northreach
Mark Swain MD, MSc, FRCPC, FAASLD, FCAHS
Cal Wenzel Family Foundation Chair in Hepatology, Professor of Medicine, Head, Division of Gastroenterology and Hepatology, University of Calgary, Section Head, Section of Gastroenterology and Hepatology, Calgary Zone, Alberta Health Services
Dr. Mark Swain is Professor and Head of the Division of Gastroenterology and Hepatology at the University of Calgary and holds the Cal Wenzel Family Foundation Chair in Hepatology. Dr. Swain has a longstanding clinical interest in the management and treatment of hepatitis C. He is President Elect for the Canadian Association for the Study of the Liver (CASL) and was inducted as a Fellow of the Canadian Academy of Health Sciences in 2019.
Fiona Clement, BSc PhD
Professor and Head, Dept of Community Health Sciences Director, Health Technology Assessment Unit
Dr. Fiona Clement is a Professor and the Department Head of Community Health Sciences within the Cumming School of Medicine at the University of Calgary. She has extensive training in Health Economics and Health Policy. She has published over 130 peer-reviewed publications, 40 Policy reports and has over $20 million dollars in funding awarded ($3.0 million as PI). She has been awarded national numerous awards recognizing her outstanding contributions to health economics and policy (the Harkness Fellowship in Health Care Policy and Practice, the Maurice McGregor Award for excellence and outstanding leadership in Health Technology Assessment, Top 100 most powerful women in Canada).
Yazid Al Harmaneh, BSc (Pharm), PhD, CDM, CAC
Scientific Officer, Alberta SPOR SUPPORT Unit/ Associate Director/Scientific Officer, EPICORE Centre, University of Alberta
Yazid is a clinical pharmacist and a researcher in the area of chronic disease prevention and management. He is currently the Scientific Officer of the Alberta SPOR Support Unit and the Associate Director/Scientific Officer of the EPICORE Centre. He obtained his BSc in pharmacy from the University of Jordan and his PhD in clinical pharmacy and pharmacy practice from Queen's University Belfast. He has a vast experience in research design and methodology and helping investigators navigate the research landscape. His main research interests are chronic disease prevention and management with special interest in cardiovascular disease and pharmacy practice research. This research involves focusing on prevention, increasing awareness, improving control and management of cardiovascular disease and its risk factors as well as making the paradigm shift in pharmacy practice to focus on patient-centered care.
Hussain Usman, MBBS, MSc, DPH, CHE
Executive Director, Public Health Surveillance & Informatics And Program Knowledge, Evidence, & Innovation, Alberta Health Services
Dr. Hussain R. Usman brings a diverse and unique set of training, experience, and background. He has a degree in medicine (M.B.B.S.), M.Sc. in Epidemiology, Dr.P.H. in Public Health, and a Fellowship in Public Health Informatics from the Centers for Disease Control and Prevention (CDC), Atlanta. With over 20 years of public health experience and significant accomplishment, Dr. Usman has authored many high impact peer reviewed articles and is a well-versed on the topics of epidemiology, public health surveillance, research, big data, and data visualization. He is currently working for Alberta Health Services (AHS) as Executive Director for Public Health Surveillance & Informatics; and Program Knowledge Evidence & Innovation.
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC, FCAHS, ISHF
Professor and Chair, Department of Pharmacology; Director, EPICORE Centre, Faculty of Medicine and Dentistry, University of Alberta
Dr. Tsuyuki has expertise in clinical trials and health services research. He has pioneered the use of pharmacists to improve health outcomes.
Christine Hughes, BScPharm, PharmD, FCSHP
Professor and Interim Dean, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta
Dr. Hughes is actively involved in teaching at the undergraduate, graduate, and post-professional level. Her research interests focus primarily on pharmacists' roles in prevention, testing, and treatment of sexually transmitted and blood-borne infections. She is also interested in the implementation and evaluation of professional pharmacy services.
Stephen Congly, MD, MSc, FRCPC, FACP, AGAF
Clinical Associate Professor of Medicine, Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary
Dr. Congly is a transplant hepatologist and health economist and is the health economics lead for the project. His interests are how to better utilize health care resources and obtain equitable access to care for all patients with liver disease including hepatitis C.
Jenny Godley, BA, MA, PhD
Associate Professor, Department of Sociology, University of Calgary; Adjunct Associate Professor, Department of Community Health Sciences, University of Calgary; Chair, Conjoint Faculties Research Ethics Board, University of Calgary
Dr. Jenny Godley is a quantitative sociologist, trained in demography and social network analysis. She is an Associate Professor in the Department of Sociology at the University of Calgary. Her research focuses on understanding the mechanisms through which social class and other forms of social inequality affect health.
Leanne Reeb, BSW, MBA
Executive Director, Digestive Health Strategic Clinical NetworkTM Provincial Clinical Excellence, Alberta Health Services
Leanne works with stakeholders from across Alberta to plan, implement, and evaluate initiatives that improve quality of care and outcomes for patients with digestive health conditions. Much of her work focuses on care in primary care settings, and she is excited about this project to optimize the role of pharmacists and community-based organizations in HCV care.
Abdel Aziz Shaheen, MBBCh, MPH, FRCPC
Assistant Professor, Department of Medicine and Community Health Sciences. Division of Gastroenterology and Hepatology, O'Brian Institute for Public Health Cumming School of Medicine, University of Calgary
Dr. Shaheen is an epidemiologist and gastroenterologist. His research program is focused on studying chronic liver diseases outcomes and improving care based on evaluating current health care delivery methods.
Kelly J Mrklas, BSc BSc MSc Doctoral Candidate
Knowledge Translation Implementation Scientist, Strategic Clinical NetworksTM, Provincial Clinical Excellence, Alberta Health Services
As an Implementation Scientist, Kelly Mrklas helps clinicians, researchers, and decision-makers turn high quality knowledge into effective, sustainable daily work. Kelly is a named investigator on 30+ implementation/research projects. She authored the AHS Innovation Pipeline, an evidence-based innovation mapping approach adopted by Alberta Health Services, health research funders, and non-profit organizations to guide impactful innovation investment, evaluation and strategic planning.
Cari Egan, RN, BN, MSc, PhD
Partnerships and Implementation Science Lead, Research and Innovation, Public Health Evidence and Innovation, Alberta Health Services
Dr. Cari Egan has an extensive background in Sexually Transmitted and Blood Borne Infections and sexual health. Cari collaborates with multi-disciplinary healthcare, social services, and industry stakeholders across Alberta to co-design, implement and evaluate low-barrier innovation strategies to improve equity in access to healthcare and health outcomes.
April Calliou, PaCer
Honor Life Coordinator, Alberta Health Services
April Calliou is the Honouring Life Coordinator with the Indigenous Wellness Core at Alberta Health Services. April is working as our Indigenous PaCer Researcher. April graduated from the Indigenous PaCer Research program in 2018, from the University of Calgary, and after the program she continued on with the mentorship program with PaCer (Patient and Community Engagement Research).
Alexandra Kanters, BA, MPH
Project Lead, University of Calgary
Alexandra is the project manager for the LiveRx study. Her academic background is in health promotion, and she brings significant research administration experience to the project. Her research interests focus on health equity and research ethics, and she is currently working towards her PhD in Community Health Sciences at the University of Calgary.
Stephanie Gysel, BScPharm, PharmD
Post-Doctoral Research Fellow, University of Alberta
Dr. Stephanie Gysel is a clinical pharmacist in Calgary and postdoctoral research fellow at the University of Alberta working on several projects with the EPICORE Centre and community pharmacies. She is passionate about pharmacy practice-based research and hopes to create novel pharmacist-led programs to fill gaps in our health care system.
Sandra Johansen, PhD
Evaluation Team Lead, Performance, Program and Impact,Provincial Population and Public Health,Alberta Health Services
Dr Johansen has extensive experience in program evaluation, applied research, and program management of population and public health initiatives.
Pharmacies
CBOs